AZN
Price
$72.88
Change
+$0.53 (+0.73%)
Updated
Jun 6 closing price
Capitalization
208.98B
45 days until earnings call
MRK
Price
$78.97
Change
+$1.35 (+1.74%)
Updated
Jun 6 closing price
Capitalization
331.75B
50 days until earnings call
Interact to see
Advertisement

AZN vs MRK

Header iconAZN vs MRK Comparison
Open Charts AZN vs MRKBanner chart's image
AstraZeneca
Price$72.88
Change+$0.53 (+0.73%)
Volume$2.45M
Capitalization208.98B
Merck & Co
Price$78.97
Change+$1.35 (+1.74%)
Volume$9.86M
Capitalization331.75B
AZN vs MRK Comparison Chart
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. MRK commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Buy and MRK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (AZN: $70.38 vs. MRK: $76.17)
Brand notoriety: AZN and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 66% vs. MRK: 78%
Market capitalization -- AZN: $208.98B vs. MRK: $331.75B
AZN [@Pharmaceuticals: Major] is valued at $208.98B. MRK’s [@Pharmaceuticals: Major] market capitalization is $331.75B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whileMRK’s FA Score has 2 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • MRK’s FA Score: 2 green, 3 red.
According to our system of comparison, AZN is a better buy in the long-term than MRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 5 TA indicator(s) are bullish while MRK’s TA Score has 5 bullish TA indicator(s).

  • AZN’s TA Score: 5 bullish, 3 bearish.
  • MRK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, AZN is a better buy in the short-term than MRK.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +1.00% price change this week, while MRK (@Pharmaceuticals: Major) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.22%. For the same industry, the average monthly price growth was +3.78%, and the average quarterly price growth was +3.49%.

Reported Earning Dates

AZN is expected to report earnings on Jul 24, 2025.

MRK is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.22% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($332B) has a higher market cap than AZN($209B). MRK has higher P/E ratio than AZN: MRK (935.64) vs AZN (35.30). AZN YTD gains are higher at: 8.952 vs. MRK (-22.770). AZN has higher annual earnings (EBITDA): 13.4B vs. MRK (6.91B). MRK has more cash in the bank: 7.09B vs. AZN (5.86B). AZN has less debt than MRK: AZN (28.6B) vs MRK (35.1B). MRK has higher revenues than AZN: MRK (60.1B) vs AZN (45.8B).
AZNMRKAZN / MRK
Capitalization209B332B63%
EBITDA13.4B6.91B194%
Gain YTD8.952-22.770-39%
P/E Ratio35.30935.644%
Revenue45.8B60.1B76%
Total Cash5.86B7.09B83%
Total Debt28.6B35.1B81%
FUNDAMENTALS RATINGS
AZN vs MRK: Fundamental Ratings
AZN
MRK
OUTLOOK RATING
1..100
168
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
3977
SMR RATING
1..100
5024
PRICE GROWTH RATING
1..100
5664
P/E GROWTH RATING
1..100
80100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (9) in the Pharmaceuticals Major industry is in the same range as AZN (24). This means that MRK’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (39) in the Pharmaceuticals Major industry is somewhat better than the same rating for MRK (77). This means that AZN’s stock grew somewhat faster than MRK’s over the last 12 months.

MRK's SMR Rating (24) in the Pharmaceuticals Major industry is in the same range as AZN (50). This means that MRK’s stock grew similarly to AZN’s over the last 12 months.

AZN's Price Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as MRK (64). This means that AZN’s stock grew similarly to MRK’s over the last 12 months.

AZN's P/E Growth Rating (80) in the Pharmaceuticals Major industry is in the same range as MRK (100). This means that AZN’s stock grew similarly to MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNMRK
RSI
ODDS (%)
N/A
Bullish Trend 13 days ago
41%
Stochastic
ODDS (%)
Bearish Trend 13 days ago
45%
Bullish Trend 13 days ago
55%
Momentum
ODDS (%)
Bullish Trend 13 days ago
59%
Bearish Trend 13 days ago
51%
MACD
ODDS (%)
Bullish Trend 13 days ago
52%
Bullish Trend 13 days ago
40%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
55%
Bearish Trend 13 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
53%
Bearish Trend 13 days ago
45%
Advances
ODDS (%)
Bullish Trend 14 days ago
54%
Bullish Trend 14 days ago
48%
Declines
ODDS (%)
Bearish Trend 27 days ago
45%
Bearish Trend 27 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
48%
Bullish Trend 13 days ago
54%
Aroon
ODDS (%)
Bullish Trend 13 days ago
42%
Bearish Trend 13 days ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with NVS. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
-0.82%
NVS - AZN
62%
Loosely correlated
-1.18%
GSK - AZN
53%
Loosely correlated
-0.66%
SNY - AZN
48%
Loosely correlated
-0.76%
PFE - AZN
45%
Loosely correlated
-1.82%
LLY - AZN
45%
Loosely correlated
-0.80%
More

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-1.83%
PFE - MRK
46%
Loosely correlated
-1.82%
BIIB - MRK
41%
Loosely correlated
-0.67%
AMGN - MRK
41%
Loosely correlated
-0.38%
ABBV - MRK
41%
Loosely correlated
-1.42%
AZN - MRK
40%
Loosely correlated
-0.82%
More